Section Arrow
XENE.NASDAQ
- Xenon Pharmaceuticals
Quotes are at least 15-min delayed:2025/09/05 18:00 EDT
After Hours
Last
 39.21
0 (0.00%)
Bid
34
Ask
39.25
High 39.69 
Low 38.96784 
Volume 19742 
Regular Hours
Last
 39.21
+0.57 (+1.48%)
Day High 
39.55 
Prev. Close
38.64 
1-M High
39.84 
Volume 
646.09K 
Bid
34
Ask
39.25
Day Low
38.45 
Open
38.75 
1-M Low
32.78 
Market Cap 
2.98B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 38.68 
20-SMA 37.53 
50-SMA 34.17 
52-W High 46 
52-W Low 26.74 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.55/-5.15
Enterprise Value
2.99B
Balance Sheet
Book Value Per Share
8.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GNPXGenprex0.2295+0.0738+47.40%0.18PE
After Hours 0.2099 -0.0196 -8.54%
ADAPAdaptimmune Therapeutics plc0.041-0.01-19.61%-- 
After Hours 0.0426 +0.0016 +3.90%
NUVBNuvation Bio3.9+0.48+14.04%-- 
After Hours 3.92 +0.02 +0.51%
KLTOKlotho Neurosciences Inc0.4851-0.0099-2.00%-- 
After Hours 0.4738 -0.0113 -2.33%
IOVAIovance Biotherapeutics2.49+0.29+13.18%-- 
After Hours 2.49 0 0.00%
Quotes are at least 15-min delayed:2025/09/05 18:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.